- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01947972
Individualized Maternal Milk Fortification for Feeding the Preterm Infants
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Proteins are of the most important macromolecules in living organisms participating in almost all biological processes. Premature infants are forced to adapt to a new (extrauterine) environment where supply of nutrients, including amino acids, from mother ceases abruptly. Consequently, the aim of neonatologist is the appropriate, quantitatively and qualitatively nutritional support, to promote brain development, achieve normal endocrine and metabolic function, maintain a growth rate similar to the intrauterine one avoiding extrauterine growth restriction during postnatal period and at the same time encouraging the analogue modulation of body composition (increased muscle mass, decrease body fat, hydration).
Malnutrition or inadequate nutrition of preterm infant which remains undiagnosed and without proper treatment could have serious consequences on psychomotor development and metabolic activity. Indeed, 75% of low birth weight premature infants exhibit extrauterine growth restriction at discharge, even when they have achieved growth equal to the considered satisfactory, ie 15g/kg/day.
Beyond anthropometrics differences between preterm and full-term newborns, body composition varies as well. Preterms have higher percentage of body fat and decreased muscle mass at term time compared with full term neonates. However, it has not been clarified whether this differentiation is harmful predisposing to chronic diseases later in childhood or adult life (eg. obesity, metabolic syndrome).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Thessaloniki, Greece
- Hippokration Hospital Thessaloniki
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Infants with gestational age ≤ 34weeks
- very low birth weight (≤ 1500g)
Exclusion Criteria:
- maternal health problems contradicting breastfeeding
- genetic or chromosomal abnormalities
- metabolic contraindications for increased amount of protein
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: protein intake of 4g/kg/d
Tailored protein fortification and nutritional status of preterm neonate.
4.5g protein per kg for preterms with body weight less than 1000g and 4g protein per kg for preterms with body weight more than 1000g, after human milk analysis.
Intervention regards protein supplementation to fulfil the exact protein needs of preterms
|
4-4.5g of protein/kg/d
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean protein intake per kg of body weight between the groups
Time Frame: participants will be followed until discharge and at 40 weeks post gestational age
|
participants will be followed until discharge and at 40 weeks post gestational age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
growth assessment differences between groups
Time Frame: participants will be followed until discharge and at 40 weeks post gestational age
|
Anthropometric differences in body length, head circumference, body weight gain/kg, mid arm circumference
|
participants will be followed until discharge and at 40 weeks post gestational age
|
Differences in bioelectrical impedance between groups
Time Frame: participants will be followed until discharge and at 40 weeks post gestational age
|
participants will be followed until discharge and at 40 weeks post gestational age
|
|
Mean daily dietary intake of mothers and correlation with macronutrients of their's breast milk
Time Frame: from the moment of intervention, at least once in 10days, and until the end of intervention
|
from the moment of intervention, at least once in 10days, and until the end of intervention
|
|
Biochemical (lipidemic profile differences) between groups
Time Frame: at 36weeks post conceptual age and follow-up at 40 weeks postconceptual age
|
at 36weeks post conceptual age and follow-up at 40 weeks postconceptual age
|
Collaborators and Investigators
Investigators
- Principal Investigator: Elisavet Diamanti, Dr, AUTH
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IKY5721
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
Mayo ClinicCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
-
Wageningen University and ResearchPhilips Healthcare; TNO; Friesland Campina; Albert Heijn; Menzis; Smart with food; Vi... and other collaboratorsCompletedMetabolic Syndrome, Protection AgainstNetherlands
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
University of HohenheimGerman Federal Ministry of Education and ResearchCompleted
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
-
Andalas UniversityHasanuddin University; Universitas Sumatera UtaraCompletedMetabolic Syndrome, Protection AgainstIndonesia
Clinical Trials on Tailored protein fortification
-
McMaster Children's HospitalUnknownPostnatal Growth DisorderCanada
-
University of OklahomaCompletedPremature; Infant, Light-for-datesUnited States
-
Columbia UniversityRecruitingGrowth Failure | Growth Retardation | Prematurity; Extreme | Infant Nutrition Disorders | Failure to Thrive in NewbornUnited States
-
The Hospital for Sick ChildrenRecruitingVery Low Birth Weight InfantCanada
-
McMaster Children's HospitalUnknownNeurodevelopment | Postnatal Growth DisorderCanada
-
Brigham and Women's HospitalRecruitingPreterm Birth | Neurodevelopmental Disorders | Breast Milk Expression | Nutrition Disorder, Infant | Brain Development AbnormalityUnited States
-
Centro Hospitalar de Lisboa CentralSociedade Portuguesa de NeonatologiaUnknownGrowth | Body Composition | Adiposity | Prematurity | Feeding Patterns | Nutrient Deficiency | Breast Milk CollectionPortugal
-
University of CalgaryRecruiting
-
McMaster Children's HospitalCompletedPostnatal Growth DisorderCanada
-
Children's National Research InstituteNot yet recruitingVery Low Birth Weight Infant | Very Preterm Maturity of InfantUnited States